
Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistance.
Yu, Helena, Suzawa, Ken, Jordan, Emmet J, Zehir, Ahmet, Ni, Andy, Kim, Hyunjae Ryan, Kris, Mark G., Hellmann, Matthew D., Li, Bob T., Somwar, Romel, Solit, David B., Berger, Michael F., Arcila, MariaLangue:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-2961
Date:
March, 2018
Fichier:
PDF, 3.03 MB
english, 2018